NGF and pancreatic neoplasm: Another intriguing point is the fact that ADRB2 signaling upregulates nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) expression in pancreatic cancer, and increased survival was observed in patients treated with nonselective B-blockers [133].